{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T11:08:10Z","timestamp":1791198490663,"version":"4.1.0"},"reference-count":157,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T00:00:00Z","timestamp":1318896000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nat Rev Endocrinol"],"published-print":{"date-parts":[[2012,3]]},"DOI":"10.1038\/nrendo.2011.164","type":"journal-article","created":{"date-parts":[[2011,10,18]],"date-time":"2011-10-18T13:21:47Z","timestamp":1318944107000},"page":"172-182","source":"Crossref","is-referenced-by-count":126,"title":["Neonatal gonadotropin therapy in male congenital hypogonadotropic hypogonadism"],"prefix":"10.1038","volume":"8","author":[{"given":"Claire","family":"Bouvattier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Maione","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bouligand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Dod\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Guiochon-Mantel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,10,18]]},"reference":[{"key":"BFnrendo2011164_CR1","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1530\/EJE-10-0083","volume":"162","author":"F Brioude","year":"2010","unstructured":"Brioude, F.  et al. Non-syndromic congenital hypogonadotropic hypogonadism: clinical presentation and genotype\u2013phenotype relationships. Eur. J. Endocrinol. 162, 835\u2013851 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR2","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1038\/nrendo.2009.177","volume":"5","author":"SD Bianco","year":"2009","unstructured":"Bianco, S. D. & Kaiser, U. B. The genetic and molecular basis of idiopathic hypogonadotropic hypogonadism. Nat. Rev. Endocrinol. 5, 569\u2013576 (2009).","journal-title":"Nat. Rev. Endocrinol."},{"key":"BFnrendo2011164_CR3","first-page":"249","volume":"22","author":"AL Mitchell","year":"2011","unstructured":"Mitchell, A. L., Dwyer, A., Pitteloud, N. & Quinton, R. Genetic basis and variable phenotypic expression of Kallmann syndrome: towards a unifying theory. Trends Endocrinol. Metab. 22, 249\u2013258 (2011).","journal-title":"Trends Endocrinol. Metab."},{"key":"BFnrendo2011164_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/ejhg.2008.206","volume":"17","author":"C Dod\u00e9","year":"2009","unstructured":"Dod\u00e9, C. & Hardelin, J. P. Kallmann syndrome. Eur. J. Hum. Genet. 17, 139\u2013146 (2009).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrendo2011164_CR5","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.ajhg.2008.09.005","volume":"83","author":"HG Kim","year":"2008","unstructured":"Kim, H. G.  et al. Mutations in CHD7, encoding a chromatin-remodeling protein, cause idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 83, 511\u2013519 (2008).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo2011164_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/j.1399-0004.2008.01107.x","volume":"75","author":"MC Jongmans","year":"2009","unstructured":"Jongmans, M. C.  et al. CHD7 mutations in patients initially diagnosed with Kallmann syndrome\u2014the clinical overlap with CHARGE syndrome. Clin. Genet. 75, 65\u201371 (2009).","journal-title":"Clin. Genet."},{"key":"BFnrendo2011164_CR7","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1159\/000312698","volume":"39","author":"J Sarfati","year":"2010","unstructured":"Sarfati, J., Dod\u00e9, C. & Young, J. Kallmann syndrome caused by mutations in the PROK2 and PROKR2 genes: pathophysiology and genotype\u2013phenotype correlations. Front. Horm. Res. 39, 121\u2013132 (2010).","journal-title":"Front. Horm. Res."},{"key":"BFnrendo2011164_CR8","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1111\/j.1365-2265.2008.03299.x","volume":"69","author":"Z Shoham","year":"2008","unstructured":"Shoham, Z., Smith, H., Yeko, T., O'Brien, F., Hemsey, G. & O'Dea, L. Recombinant LH (lutropin alfa) for the treatment of hypogonadotrophic women with profound LH deficiency: a randomized, double-blind, placebo-controlled, proof-of-efficacy study. Clin. Endocrinol. (Oxf.) 69, 471\u2013478 (2008).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2011164_CR9","doi-asserted-by":"publisher","first-page":"883","DOI":"10.1210\/er.2009-0016","volume":"30","author":"HM Scott","year":"2009","unstructured":"Scott, H. M., Mason, J. I. & Sharpe, R. M. Steroidogenesis in the fetal testis and its susceptibility to disruption by exogenous compounds. Endocr. Rev. 30, 883\u2013925 (2009).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2011164_CR10","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1530\/REP-10-0365","volume":"141","author":"PJ O'Shaughnessy","year":"2011","unstructured":"O'Shaughnessy, P. J. & Fowler, P. A. Endocrinology of the mammalian fetal testis. Reproduction 141, 37\u201346 (2011).","journal-title":"Reproduction"},{"key":"BFnrendo2011164_CR11","doi-asserted-by":"publisher","first-page":"791","DOI":"10.1210\/jcem-55-4-791","volume":"55","author":"RL Molsberry","year":"1982","unstructured":"Molsberry, R. L., Carr, B. R., Mendelson, C. R. & Simpson, E. R. Human chorionic gonadotropin binding to human fetal testes as a function of gestational age. J. Clin. Endocrinol. Metab. 55, 791\u2013794 (1982).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR12","doi-asserted-by":"publisher","first-page":"4688","DOI":"10.1210\/jc.2009-0994","volume":"94","author":"PA Fowler","year":"2009","unstructured":"Fowler, P. A., Bhattacharya, S., Gromoll, J., Monteiro, A. & O'Shaughnessy, P. J. Maternal smoking and developmental changes in luteinizing hormone (LH) and the LH receptor in the fetal testis. J. Clin. Endocrinol. Metab. 94, 4688\u20134695 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR13","first-page":"28","volume":"4","author":"AC Latronico","year":"2006","unstructured":"Latronico, A. C. & Arnhold, I. J. Inactivating mutations of LH and FSH receptors\u2014from genotype to phenotype. Pediatr. Endocrinol. Rev. 4, 28\u201331 (2006).","journal-title":"Pediatr. Endocrinol. Rev."},{"key":"BFnrendo2011164_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1210\/edrv-8-4-406","volume":"8","author":"JJ Mulchahey","year":"1987","unstructured":"Mulchahey, J. J., Di Blasio, A. M., Martin, M. C., Blumenfeld, Z. & Jaffe, R. B. Hormone production and peptide regulation of the human fetal pituitary gland. Endocr. Rev. 8, 406\u2013425 (1987).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2011164_CR15","doi-asserted-by":"publisher","first-page":"878","DOI":"10.1016\/0002-9378(85)90665-9","volume":"151","author":"OA Kletzky","year":"1985","unstructured":"Kletzky, O. A., Rossman, F., Bertolli, S. I., Platt, L. D. & Mishell, D. R. Jr. Dynamics of human chorionic gonadotropin, prolactin, and growth hormone in serum and amniotic fluid throughout normal human pregnancy. Am. J. Obstet. Gynecol. 151, 878\u2013884 (1985).","journal-title":"Am. J. Obstet. Gynecol."},{"key":"BFnrendo2011164_CR16","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1210\/edrv-7-3-270","volume":"7","author":"JM Hutson","year":"1986","unstructured":"Hutson, J. M. & Donahoe, P. K. The hormonal control of testicular descent. Endocr. Rev. 7, 270\u2013283 (1986).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2011164_CR17","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1210\/er.2007-0042","volume":"29","author":"C Foresta","year":"2008","unstructured":"Foresta, C., Zuccarello, D., Garolla, A. & Ferlin, A. Role of hormones, genes, and environment in human cryptorchidism. Endocr. Rev. 29, 560\u2013580 (2008).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2011164_CR18","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1038\/nrurol.2011.23","volume":"8","author":"K Bay","year":"2011","unstructured":"Bay, K., Main, K. M., Toppari, J. & Skakkeb\u00e6k, N. E. Testicular descent: INSL3, testosterone, genes and the intrauterine milieu. Nat. Rev. Urol. 8, 187\u2013196 (2011).","journal-title":"Nat. Rev. Urol."},{"key":"BFnrendo2011164_CR19","doi-asserted-by":"publisher","first-page":"764","DOI":"10.1210\/edrv.22.6.0446","volume":"22","author":"TM Plant","year":"2001","unstructured":"Plant, T. M. & Marshall, G. R. The functional significance of FSH in spermatogenesis and the control of its secretion in male primates. Endocr. Rev. 22, 764\u2013786 (2001).","journal-title":"Endocr. Rev."},{"key":"BFnrendo2011164_CR20","doi-asserted-by":"publisher","first-page":"1210","DOI":"10.1210\/jcem-65-6-1210","volume":"65","author":"IT Huhtaniemi","year":"1987","unstructured":"Huhtaniemi, I. T., Yamamoto, M., Ranta, T., Jalkanen, J. & Jaffe, R. B. Follicle-stimulating hormone receptors appear earlier in the primate fetal testis than in the ovary. J. Clin. Endocrinol. Metab. 65, 1210\u20131214 (1987).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR21","doi-asserted-by":"publisher","first-page":"4792","DOI":"10.1210\/jc.2007-1690","volume":"92","author":"P O'Shaughnessy","year":"2007","unstructured":"O'Shaughnessy, P.  et al. Developmental changes in human fetal testicular cell numbers and messenger ribonucleic acid levels during the second trimester. J. Clin. Endocrinol. Metab. 92, 4792\u20134801 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR22","doi-asserted-by":"publisher","first-page":"1818","DOI":"10.1210\/jc.2008-1909","volume":"94","author":"K Boukari","year":"2009","unstructured":"Boukari, K.  et al. Lack of androgen receptor expression in Sertoli cells accounts for the absence of anti-Mullerian hormone repression during early human testis development. J. Clin. Endocrinol. Metab. 94, 1818\u20131825 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR23","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1210\/jcem.85.1.6249","volume":"85","author":"F Debieve","year":"2000","unstructured":"Debieve, F., Beerlandt, S., Hubinont, C. & Thomas, K. Gonadotropins, prolactin, inhibin A, inhibin B, and activin A in human fetal serum from midpregnancy and term pregnancy. J. Clin. Endocrinol. Metab. 85, 270\u2013274 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR24","doi-asserted-by":"publisher","first-page":"3073","DOI":"10.1210\/endo-129-6-3073","volume":"129","author":"S Mesiano","year":"1991","unstructured":"Mesiano, S., Hart, C. S., Heyer, B. W., Kaplan, S. L. & Grumbach, M. M. Hormone ontogeny in the ovine fetus. XXVI. A sex difference in the effect of castration on the hypothalamic\u2013pituitary gonadotropin unit in the ovine fetus. Endocrinology. 129, 3073\u20133079 (1991).","journal-title":"Endocrinology."},{"key":"BFnrendo2011164_CR25","first-page":"3509","volume":"82","author":"AW Brandenberger","year":"1997","unstructured":"Brandenberger, A. W., Tee, M. K., Lee, J. Y., Chao, V. & Jaffe, R. B. Tissue distribution of estrogen receptors \u03b1 (ER-\u03b1) and \u03b2 (ER-\u03b2) mRNA in the midgestational human fetus. J. Clin. Endocrinol. Metab. 82, 3509\u20133512 (1997).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR26","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.neulet.2008.05.008","volume":"439","author":"CE Wood","year":"2008","unstructured":"Wood, C. E. & Keller-Wood, M. Ontogeny of androgen receptor expression in the ovine fetal central nervous system and pituitary. Neurosci. Lett. 439, 153\u2013156 (2008).","journal-title":"Neurosci. Lett."},{"key":"BFnrendo2011164_CR27","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.brainres.2010.09.084","volume":"1364","author":"J Bouligand","year":"2010","unstructured":"Bouligand, J.  et al. Genetics defects in GNRH1: a paradigm of hypothalamic congenital gonadotropin deficiency. Brain Res. 1364, 3\u20139 (2010).","journal-title":"Brain Res."},{"key":"BFnrendo2011164_CR28","doi-asserted-by":"publisher","first-page":"3668","DOI":"10.1172\/JCI43699","volume":"120","author":"L Teixeira","year":"2010","unstructured":"Teixeira, L.  et al. Defective migration of neuroendocrine GnRH cells in human arrhinencephalic conditions. J. Clin. Invest. 120, 3668\u20133672 (2010).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2011164_CR29","first-page":"1","volume-title":"Control of the onset of puberty","author":"MM Grumbach","year":"1990","unstructured":"Grumbach, M. M. & Kaplan, S. L. in Control of the onset of puberty (eds Grumbach, M. M., Sizonenko, P. C., Aubert, M. L.) 1\u201368 (Williams & Wilkins, Baltimore, 1990)."},{"key":"BFnrendo2011164_CR30","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1002\/(SICI)1096-9861(19960311)366:3<547::AID-CNE12>3.0.CO;2-M","volume":"366","author":"M Schwanzel-Fukuda","year":"1996","unstructured":"Schwanzel-Fukuda, M.  et al. Migration of luteinizing hormone-releasing hormone (LHRH) neurons in early human embryos. J. Comp. Neurol. 366, 547\u2013557 (1996).","journal-title":"J. Comp. Neurol."},{"key":"BFnrendo2011164_CR31","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.yfrne.2004.06.001","volume":"25","author":"D Gonz\u00e1lez-Mart\u00ednez","year":"2004","unstructured":"Gonz\u00e1lez-Mart\u00ednez, D., Hu, Y. & Bouloux, P. M. Ontogeny of GnRH and olfactory neuronal systems in man: novel insights from the investigation of inherited forms of Kallmann's syndrome. Front. Neuroendocrinol. 25, 108\u2013130 (2004).","journal-title":"Front. Neuroendocrinol."},{"key":"BFnrendo2011164_CR32","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1210\/endo-115-5-1774","volume":"115","author":"SJ Clark","year":"1984","unstructured":"Clark, S. J.  et al. Hormone ontogeny in the ovine fetus. XVII. Demonstration of pulsatile luteinizing hormone secretion by the fetal pituitary gland. Endocrinology 115, 1774\u20131779 (1984).","journal-title":"Endocrinology"},{"key":"BFnrendo2011164_CR33","doi-asserted-by":"publisher","first-page":"1038","DOI":"10.1210\/jcem-73-5-1038","volume":"73","author":"L Liu","year":"1991","unstructured":"Liu, L.  et al. Effects of pituitary-testicular axis suppression in utero and during the early neonatal period with a long-acting luteinizing hormone-releasing hormone analog on genital development, somatic growth, and bone density in male cynomolgus monkeys in the first 6 months of life. J. Clin. Endocrinol. Metab. 73, 1038\u20131043 (1991).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR34","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1677\/joe.0.1410317","volume":"141","author":"GB Thomas","year":"1994","unstructured":"Thomas, G. B., McNeilly, A. S., Gibson, F. & Brooks, A. N. Effects of pituitary-gonadal suppression with a gonadotrophin-releasing hormone agonist on fetal gonadotrophin secretion, fetal gonadal development and maternal steroid secretion in the sheep. J. Endocrinol. 141, 317\u2013324 (1994).","journal-title":"J. Endocrinol."},{"key":"BFnrendo2011164_CR35","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/978-1-4615-0621-8_4","volume":"511","author":"DA Husmann","year":"2002","unstructured":"Husmann, D. A. Micropenis: an animal model and its human correlates. Adv. Exp. Med. Biol. 511, 41\u201354 (2002).","journal-title":"Adv. Exp. Med. Biol."},{"key":"BFnrendo2011164_CR36","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1530\/jrf.0.0600193","volume":"60","author":"TG Baker","year":"1980","unstructured":"Baker, T. G. & Scrimgeour, J. B. Development of the gonad in normal and anencephalic human fetuses. J. Reprod. Fertil. 60, 193\u2013199 (1980).","journal-title":"J. Reprod. Fertil."},{"key":"BFnrendo2011164_CR37","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1159\/000179445","volume":"15","author":"L Cavallo","year":"1981","unstructured":"Cavallo, L.  et al. Endocrine function in four anencephalic infants. Horm. Res. 15, 159\u2013166 (1981).","journal-title":"Horm. Res."},{"key":"BFnrendo2011164_CR38","doi-asserted-by":"publisher","first-page":"2742","DOI":"10.1056\/NEJMoa0900136","volume":"360","author":"J Bouligand","year":"2009","unstructured":"Bouligand, J.  et al. Isolated familial hypogonadotropic hypogonadism and a GNRH1 mutation. N. Eng. J. Med. 360, 2742\u20132748 (2009).","journal-title":"N. Eng. J. Med."},{"key":"BFnrendo2011164_CR39","doi-asserted-by":"publisher","first-page":"11703","DOI":"10.1073\/pnas.0903449106","volume":"106","author":"YM Chan","year":"2009","unstructured":"Chan, Y. M.  et al. GNRH1 mutations in patients with idiopathic hypogonadotropic hypogonadism. Proc. Natl Acad. Sci. USA 106, 11703\u201311708 (2009).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2011164_CR40","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJM199711273372205","volume":"337","author":"N de Roux","year":"1997","unstructured":"de Roux, N.  et al. A family with hypogonadotropic hypogonadism and mutations in the gonadotropin-releasing hormone receptor. N. Eng. J. Med. 337, 1597\u2013602 (1997).","journal-title":"N. Eng. J. Med."},{"key":"BFnrendo2011164_CR41","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1210\/jcem.84.3.5518","volume":"84","author":"P Caron","year":"1999","unstructured":"Caron, P.  et al. Resistance of hypogonadic patients with mutated GnRH receptor genes to pulsatile GnRH administration. J. Clin. Endocrinol. Metab. 84, 990\u2013996 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR42","first-page":"3811","volume":"84","author":"FP Pralong","year":"1999","unstructured":"Pralong, F. P.  et al. Complete hypogonadotropic hypogonadism associated with a novel inactivating mutation of the gonadotropin-releasing hormone receptor. J. Clin. Endocrinol. Metab. 84, 3811\u20133816 (1999).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1046\/j.1365-2265.2001.01211.x","volume":"54","author":"D S\u00f6derlund","year":"2001","unstructured":"S\u00f6derlund, D., Canto, P., de la Chesnaye, E., Ulloa-Aguirre, A. & M\u00e9ndez, J. P. A novel homozygous mutation in the second transmembrane domain of the gonadotrophin releasing hormone receptor gene. Clin. Endocrinol. (Oxf.) 54, 493\u2013498 (2001).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2011164_CR44","first-page":"2680","volume":"86","author":"EM Costa","year":"2001","unstructured":"Costa, E. M.  et al. Two novel mutations in the gonadotropin-releasing hormone receptor gene in Brazilian patients with hypogonadotropic hypogonadism and normal olfaction. J. Clin. Endocrinol. Metab. 86, 2680\u20132686 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR45","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/S0015-0282(02)04341-8","volume":"78","author":"LC Layman","year":"2002","unstructured":"Layman, L. C., Cohen, D. P., Xie, J. & Smith, G. D. Clinical phenotype and infertility treatment in a male with hypogonadotropic hypogonadism due to mutations Ala129Asp\/Arg262Gln of the gonadotropin-releasing hormone receptor. Fertil. Steril. 78, 1317\u20131320 (2002).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR46","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1016\/S0015-0282(02)04667-8","volume":"79","author":"S Wolczynski","year":"2003","unstructured":"Wolczynski, S.  et al. A case of complete hypogonadotropic hypogonadism with a mutation in the gonadotropin-releasing hormone receptor gene. Fertil. Steril. 79, 442\u2013444 (2003).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR47","doi-asserted-by":"publisher","first-page":"1873","DOI":"10.1210\/jc.2002-020005","volume":"88","author":"B Karges","year":"2003","unstructured":"Karges, B.  et al. Mutation Ala(171)Thr stabilizes the gonadotropin-releasing hormone receptor in its inactive conformation, causing familial hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 88, 1873\u20131879 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR48","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1210\/jc.2004-1418","volume":"90","author":"RK Semple","year":"2005","unstructured":"Semple, R. K.  et al. Two novel missense mutations in g protein-coupled receptor 54 in a patient with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 90, 1849\u20131855 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR49","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1530\/eje.1.02031","volume":"153","author":"F Lanfranco","year":"2005","unstructured":"Lanfranco, F.  et al. Role of sequence variations of the GnRH receptor and G protein-coupled receptor 54 gene in male idiopathic hypogonadotropic hypogonadism. Eur. J. Endocrinol. 153, 845\u2013852 (2005).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR50","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1210\/jc.2006-2147","volume":"92","author":"Y Tenenbaum-Rakover","year":"2007","unstructured":"Tenenbaum-Rakover, Y.  et al. Neuroendocrine phenotype analysis in five patients with isolated hypogonadotropic hypogonadism due to a L102P inactivating mutation of GPR54. J. Clin. Endocrinol. Metab. 92, 1137\u20131144 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR51","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1530\/EJE-10-0012","volume":"163","author":"MG Teles","year":"2010","unstructured":"Teles, M. G.  et al. A novel homozygous splice acceptor site mutation of KISS1R in two siblings with normosmic isolated hypogonadotropic hypogonadism. Eur. J. Endocrinol. 163, 29\u201334 (2010).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR52","doi-asserted-by":"publisher","first-page":"E536","DOI":"10.1210\/jc.2010-1676","volume":"96","author":"R Nimri","year":"2011","unstructured":"Nimri, R.  et al. A novel loss-of-function mutation in GPR54\/KISS1R leads to hypogonadotropic hypogonadism in a highly consanguineous family. J. Clin. Endocrinol. Metab. 96, E536\u2013E545 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR53","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1038\/ng.306","volume":"41","author":"AK Topaloglu","year":"2009","unstructured":"Topaloglu, A. K.  et al. TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction. Nat. Genet. 41, 354\u2013358 (2009).","journal-title":"Nat. Genet."},{"key":"BFnrendo2011164_CR54","doi-asserted-by":"publisher","first-page":"3633","DOI":"10.1210\/jc.2009-0551","volume":"94","author":"T Guran","year":"2009","unstructured":"Guran, T.  et al. Hypogonadotropic hypogonadism due to a novel missense mutation in the first extracellular loop of the neurokinin B receptor. J. Clin. Endocrinol. Metab. 94, 3633\u20133639 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR55","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.1210\/jc.2009-2600","volume":"95","author":"J Young","year":"2010","unstructured":"Young, J.  et al. TAC3 and TACR3 defects cause hypothalamic congenital hypogonadotropic hypogonadism in humans. J. Clin. Endocrinol. Metab. 95, 2287\u20132295 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR56","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.mce.2006.04.021","volume":"254\u2013255","author":"N Pitteloud","year":"2006","unstructured":"Pitteloud, N.  et al. Mutations in fibroblast growth factor receptor 1 cause Kallmann syndrome with a wide spectrum of reproductive phenotypes. Mol. Cell. Endocrinol. 254\u2013255, 60\u201369 (2006).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo2011164_CR57","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1210\/jc.2007-1168","volume":"3","author":"S Salenave","year":"2008","unstructured":"Salenave, S.  et al. Kallmann's syndrome: a comparison of the reproductive phenotypes in men carrying KAL1 and FGFR1\/KAL2 mutations. J. Clin. Endocrinol. Metab. 3, 758\u2013763 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR58","doi-asserted-by":"publisher","first-page":"2857","DOI":"10.1210\/jc.2009-2320","volume":"95","author":"E Gianetti","year":"2010","unstructured":"Gianetti, E.  et al. TAC3\/TACR3 mutations reveal preferential activation of gonadotropin-releasing hormone release by neurokinin B in neonatal life followed by reversal in adulthood. J. Clin. Endocrinol. Metab. 95, 2857\u20132867 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR59","first-page":"827","volume":"76","author":"JP Hardelin","year":"1993","unstructured":"Hardelin, J. P.  et al. Xp22.3 deletions in isolated familial Kallmann's syndrome. J. Clin. Endocrinol. Metab. 76, 827\u2013831 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR60","doi-asserted-by":"publisher","first-page":"8190","DOI":"10.1073\/pnas.89.17.8190","volume":"89","author":"JP Hardelin","year":"1992","unstructured":"Hardelin, J. P.  et al. X chromosome-linked Kallmann syndrome: stop mutations validate the candidate gene. Proc. Natl Acad. Sci. USA 89, 8190\u20138194 (1992).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2011164_CR61","doi-asserted-by":"publisher","first-page":"838","DOI":"10.1136\/jmg.30.10.838","volume":"30","author":"A Meindl","year":"1993","unstructured":"Meindl, A.  et al. Analysis of a terminal Xp22.3 deletion in a patient with six monogenic disorders: implications for the mapping of X linked ocular albinism. J. Med. Genet. 30, 838\u2013842 (1993).","journal-title":"J. Med. Genet."},{"key":"BFnrendo2011164_CR62","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1006\/mgme.1998.2732","volume":"65","author":"WX Gu","year":"1998","unstructured":"Gu, W. X., Colquhoun-Kerr, J. S., Kopp, P., Bode, H. H. & Jameson, J. L. A novel aminoterminal mutation in the KAL-1 gene in a large pedigree with X-linked Kallmann syndrome. Mol. Genet. Metab. 65, 59\u201361 (1998).","journal-title":"Mol. Genet. Metab."},{"key":"BFnrendo2011164_CR63","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1111\/j.1399-0004.1998.tb03692.x","volume":"54","author":"R Weiss\u00f6rtel","year":"1998","unstructured":"Weiss\u00f6rtel, R., Strom, T. M., D\u00f6rr, H.G., Rauch, A. & Meitinger, T. Analysis of an interstitial deletion in a patient with Kallmann syndrome, X-linked ichthyosis and mental retardation. Clin. Genet. 54, 45\u201351 (1998).","journal-title":"Clin. Genet."},{"key":"BFnrendo2011164_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1007\/s100380070033","volume":"45","author":"K Nagata","year":"2000","unstructured":"Nagata, K.  et al. A novel interstitial deletion of KAL1 in a Japanese family with Kallmann syndrome. J. Hum. Genet. 45, 237\u2013240 (2000).","journal-title":"J. Hum. Genet."},{"key":"BFnrendo2011164_CR65","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1046\/j.1365-2265.2001.01277.x","volume":"55","author":"R Quinton","year":"2001","unstructured":"Quinton, R.  et al. Idiopathic gonadotrophin deficiency: genetic questions addressed through phenotypic characterization. Clin. Endocrinol. (Oxf.) 55, 163\u2013174 (2001).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2011164_CR66","first-page":"1532","volume":"86","author":"LM Oliveira","year":"2001","unstructured":"Oliveira, L. M.  et al. The importance of autosomal genes in Kallmann syndrome: genotype\u2013phenotype correlations and neuroendocrine characteristics. J. Clin. Endocrinol. Metab. 86, 1532\u20131538 (2001).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR67","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.1210\/jcem.87.6.8611","volume":"87","author":"D S\u00f6derlund","year":"2002","unstructured":"S\u00f6derlund, D., Canto, P., M\u00e9ndez, J. P. Identification of three novel mutations in the KAL1 gene in patients with Kallmann syndrome. J. Clin. Endocrinol. Metab. 87, 2589\u20132592 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR68","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1210\/jc.2002-021981","volume":"88","author":"N Massin","year":"2003","unstructured":"Massin, N.  et al. X chromosome-linked Kallmann syndrome: clinical heterogeneity in three siblings carrying an intragenic deletion of the KAL-1 gene. J. Clin. Endocrinol. Metab. 88, 2003\u20132008 (2003).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR69","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1210\/jc.2003-030476","volume":"89","author":"N Sato","year":"2004","unstructured":"Sato, N.  et al. Clinical assessment and mutation analysis of Kallmann syndrome 1 (KAL1) and fibroblast growth factor receptor 1 (FGFR1, or KAL2) in five families and 18 sporadic patients. J. Clin. Endocrinol. Metab. 89, 1079\u20131088 (2004).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR70","doi-asserted-by":"publisher","first-page":"2173","DOI":"10.1093\/humrep\/dei052","volume":"20","author":"N Sato","year":"2005","unstructured":"Sato, N.  et al. Gonadotrophin therapy in Kallmann syndrome caused by heterozygous mutations of the gene for fibroblast growth factor receptor 1: report of three families: case report. Hum. Reprod. 20, 2173\u20132178 (2005).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2011164_CR71","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.mce.2006.04.006","volume":"254\u2013255","author":"D Zenaty","year":"2006","unstructured":"Zenaty, D.  et al. Paediatric phenotype of Kallmann syndrome due to mutations of fibroblast growth factor receptor 1 (FGFR1). Mol. Cell. Endocrinol. 254\u2013255, 78\u201383 (2006).","journal-title":"Mol. Cell. Endocrinol."},{"key":"BFnrendo2011164_CR72","doi-asserted-by":"publisher","first-page":"6281","DOI":"10.1073\/pnas.0600962103","volume":"103","author":"N Pitteloud","year":"2006","unstructured":"Pitteloud, N.  et al. Mutations in fibroblast growth factor receptor 1 cause both Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl Acad. Sci. USA 103, 6281\u20136286 (2006).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2011164_CR73","doi-asserted-by":"publisher","first-page":"1415","DOI":"10.1210\/jc.2005-2266","volume":"91","author":"N Sato","year":"2006","unstructured":"Sato, N., Ohyama, K., Fukami, M., Okada, M. & Ogata, T. Kallmann syndrome: somatic and germline mutations of the fibroblast growth factor receptor 1 gene in a mother and the son. J. Clin. Endocrinol. Metab. 91, 1415\u20131418 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR74","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1172\/JCI29884","volume":"2","author":"N Pitteloud","year":"2007","unstructured":"Pitteloud, N.  et al. Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism. J. Clin. Invest. 2, 457\u2013463 (2007).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2011164_CR75","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1210\/jc.2006-1183","volume":"92","author":"N Xu","year":"2007","unstructured":"Xu, N.  et al. A mutation in the fibroblast growth factor receptor 1 gene causes fully penetrant normosmic isolated hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 92, 1155\u20131158 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR76","doi-asserted-by":"publisher","first-page":"2822","DOI":"10.1172\/JCI34538","volume":"118","author":"J Falardeau","year":"2008","unstructured":"Falardeau, J.  et al. Decreased FGF8 signaling causes deficiency of gonadotropin-releasing hormone in humans and mice. J. Clin. Invest. 118, 2822\u20132831 (2008).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2011164_CR77","doi-asserted-by":"publisher","first-page":"3491","DOI":"10.1210\/jc.2010-0176","volume":"95","author":"EB Trarbach","year":"2010","unstructured":"Trarbach, E. B.  et al. Nonsense mutations in FGF8 gene causing different degrees of human gonadotropin-releasing deficiency. J. Clin. Endocrinol. Metab. 95, 3491\u20133496 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR78","doi-asserted-by":"publisher","first-page":"17447","DOI":"10.1073\/pnas.0707173104","volume":"104","author":"N Pitteloud","year":"2007","unstructured":"Pitteloud, N.  et al. Loss-of-function mutation in the prokineticin 2 gene causes Kallmann syndrome and normosmic idiopathic hypogonadotropic hypogonadism. Proc. Natl Acad. Sci. USA 104, 17447\u201317452 (2007).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"BFnrendo2011164_CR79","doi-asserted-by":"publisher","first-page":"3551","DOI":"10.1210\/jc.2007-2654","volume":"93","author":"LW Cole","year":"2008","unstructured":"Cole, L. W.  et al. Mutations in prokineticin 2 and prokineticin receptor 2 genes in human gonadotrophin-releasing hormone deficiency: molecular genetics and clinical spectrum. J. Clin. Endocrinol. Metab. 93, 3551\u20133559 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR80","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1038\/ejhg.2008.15","volume":"16","author":"C Leroy","year":"2008","unstructured":"Leroy, C.  et al. Biallelic mutations in the prokineticin-2 gene in two sporadic cases of Kallmann syndrome. Eur. J. Hum. Genet. 16, 865\u2013868 (2008).","journal-title":"Eur. J. Hum. Genet."},{"key":"BFnrendo2011164_CR81","doi-asserted-by":"publisher","first-page":"4113","DOI":"10.1210\/jc.2008-0958","volume":"93","author":"AP Abreu","year":"2008","unstructured":"Abreu, A. P.  et al. Loss-of-function mutations in the genes encoding prokineticin-2 or prokineticin receptor-2 cause autosomal recessive Kallmann syndrome. J. Clin. Endocrinol. Metab. 93, 4113\u20134118 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR82","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1210\/jc.2009-0843","volume":"95","author":"J Sarfati","year":"2010","unstructured":"Sarfati, J.  et al. A comparative phenotypic study of kallmann syndrome patients carrying monoallelic and biallelic mutations in the prokineticin 2 or prokineticin receptor 2 genes. J. Clin. Endocrinol. Metab. 95, 659\u2013669 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR83","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1016\/j.ajhg.2010.08.018","volume":"87","author":"HG Kim","year":"2010","unstructured":"Kim, H. G.  et al. WDR11, a WD protein that interacts with transcription factor EMX1, is mutated in idiopathic hypogonadotropic hypogonadism and Kallmann syndrome. Am. J. Hum. Genet. 87, 465\u2013479 (2010).","journal-title":"Am. J. Hum. Genet."},{"key":"BFnrendo2011164_CR84","doi-asserted-by":"publisher","first-page":"1613","DOI":"10.1016\/j.fertnstert.2011.01.010","volume":"95","author":"N Xu","year":"2011","unstructured":"Xu, N.  et al. Nasal embryonic LHRH factor (NELF) mutations in patients with normosmic hypogonadotropic hypogonadism and Kallmann syndrome. Fertil. Steril. 95, 1613\u20131620.e1\u2013e7 (2011).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR85","doi-asserted-by":"publisher","first-page":"4880","DOI":"10.1210\/jc.2005-0119","volume":"90","author":"R Reynaud","year":"2005","unstructured":"Reynaud, R.  et al. An uncommon phenotype with familial central hypogonadism caused by a novel PROP1 gene mutant truncated in the transactivation domain. J. Clin. Endocrinol. Metab. 90, 4880\u20134887 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR86","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1056\/NEJM199201163260306","volume":"326","author":"J Weiss","year":"1992","unstructured":"Weiss, J.  et al. Hypogonadism caused by a single amino acid substitution in the \u03b2 subunit of luteinizing hormone. N. Eng. J. Med. 326, 179\u2013183 (1992).","journal-title":"N. Eng. J. Med."},{"key":"BFnrendo2011164_CR87","doi-asserted-by":"publisher","first-page":"2619","DOI":"10.1056\/NEJMoa040326","volume":"351","author":"H Valdes-Socin","year":"2004","unstructured":"Valdes-Socin, H.  et al. Hypogonadism in a patient with a mutation in the luteinizing hormone \u03b2-subunit gene. N. Eng. J. Med. 351, 2619\u20132625 (2004).","journal-title":"N. Eng. J. Med."},{"key":"BFnrendo2011164_CR88","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1056\/NEJMoa071999","volume":"357","author":"A Lofrano-Porto","year":"2007","unstructured":"Lofrano-Porto, A.  et al. Luteinizing hormone \u03b2 mutation and hypogonadism in men and women. N. Eng. J. Med. 357, 897\u2013904 (2007).","journal-title":"N. Eng. J. Med."},{"key":"BFnrendo2011164_CR89","doi-asserted-by":"publisher","first-page":"3410","DOI":"10.1210\/jc.2004-2257","volume":"90","author":"K Bay","year":"2005","unstructured":"Bay, K.  et al. Insulin-like factor 3 serum levels in 135 normal men and 85 men with testicular disorders: relationship to the luteinizing hormone-testosterone axis. J. Clin. Endocrinol. Metab. 90, 3410\u20133418 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR90","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.1210\/jc.2007-0974","volume":"92","author":"K Bay","year":"2007","unstructured":"Bay, K.  et al. Insulin-like factor 3 levels in cord blood and serum from children: effects of age, postnatal hypothalamic-pituitary-gonadal axis activation, and cryptorchidism. J. Clin. Endocrinol. Metab. 92, 4020\u20134027 (2007).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR91","doi-asserted-by":"publisher","first-page":"3239","DOI":"10.1210\/jcem.85.9.6811","volume":"85","author":"J Young","year":"2000","unstructured":"Young, J.  et al. Effects of human recombinant luteinizing hormone and follicle-stimulating hormone in patients with acquired hypogonadotropic hypogonadism: study of Sertoli and Leydig cell secretions and interactions. J. Clin. Endocrinol. Metab. 85, 3239\u20133244 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR92","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1210\/jc.2004-0542","volume":"90","author":"J Young","year":"2005","unstructured":"Young, J.  et al. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 90, 724\u2013728 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR93","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1038\/ng0297-205","volume":"15","author":"JS Tapanainen","year":"1997","unstructured":"Tapanainen, J. S., Aittom\u00e4ki, K., Min, J., Vaskivuo, T. & Huhtaniemi, I. T. Men homozygous for an inactivating mutation of the follicle-stimulating hormone (FSH) receptor gene present variable suppression of spermatogenesis and fertility. Nat. Genet. 15, 205\u2013206 (1997).","journal-title":"Nat. Genet."},{"key":"BFnrendo2011164_CR94","doi-asserted-by":"publisher","first-page":"663","DOI":"10.1515\/CCLM.1998.118","volume":"36","author":"G Lindstedt","year":"1998","unstructured":"Lindstedt, G.  et al. Follitropin (FSH) deficiency in an infertile male due to FSH beta gene mutation. A syndrome of normal puberty and virilization but underdeveloped testicles with azoospermia, low FSH but high lutropin and normal serum testosterone concentrations. Clin. Chem. Lab. Med. 36, 663\u2013665 (1998).","journal-title":"Clin. Chem. Lab. Med."},{"key":"BFnrendo2011164_CR95","first-page":"3702","volume":"87","author":"LC Layman","year":"2002","unstructured":"Layman, L. C.  et al. FSH beta gene mutations in a female with partial breast development and a male sibling with normal puberty and azoospermia. J. Clin. Endocrinol. Metab. 87, 3702\u20133707 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR96","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1210\/jcem-40-4-545","volume":"40","author":"JS Winter","year":"1975","unstructured":"Winter, J. S., Faiman, C., Hobson, W. C., Prasad, A. V. & Reyes, F. I. Pituitary\u2013gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J. Clin. Endocrinol. Metab. 40, 545\u2013551 (1975).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR97","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/BF00441173","volume":"137","author":"F Waldhauser","year":"1981","unstructured":"Waldhauser, F., Weibenssacher, G., Frisch, H. & Pollak, A. Pulsatile secretion of gonadotropins in early infancy. Eur. J. Pediatr. 137, 71\u201374 (1981).","journal-title":"Eur. J. Pediatr."},{"key":"BFnrendo2011164_CR98","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1111\/j.1365-2605.1983.tb00333.x","volume":"6","author":"J M\u00fcller","year":"1983","unstructured":"M\u00fcller, J. & Skakkebaek, N. E. Quantification of germ cells and seminiferous tubules by stereological examination of testicles from 50 boys who suffered from sudden death. Int. J. Androl. 6, 143\u2013156 (1983).","journal-title":"Int. J. Androl."},{"key":"BFnrendo2011164_CR99","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1530\/eje.1.02066","volume":"154","author":"M Boas","year":"2006","unstructured":"Boas, M.  et al. Postnatal penile length and growth rate correlate to serum testosterone levels: a longitudinal study of 1,962 normal boys. Eur. J. Endocrinol. 154, 125\u2013129 (2006).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR100","first-page":"675","volume":"83","author":"A Andersson","year":"1998","unstructured":"Andersson, A.  et al. Longitudinal reproductive hormone profiles in infants: peak of inhibin B levels in infant boys exceeds levels in adult men. J. Clin. Endocrinol. Metab. 83, 675\u2013681 (1998).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR101","doi-asserted-by":"publisher","first-page":"3122","DOI":"10.1210\/jc.2004-2465","volume":"90","author":"MM Grumbach","year":"2005","unstructured":"Grumbach, M. M. A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant. J. Clin. Endocrinol. Metab. 90, 3122\u20133127 (2005).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR102","doi-asserted-by":"publisher","first-page":"4092","DOI":"10.1210\/jc.2006-1079","volume":"91","author":"I Bergad\u00e1","year":"2006","unstructured":"Bergad\u00e1, I.  et al. Time course of the serum gonadotropin surge, inhibins, and anti-M\u00fcllerian hormone in normal newborn males during the first month of life. J. Clin. Endocrinol. Metab. 91, 4092\u20134098 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR103","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1111\/j.1365-2605.1987.tb00358.x","volume":"10","author":"D Cortes","year":"1987","unstructured":"Cortes, D., M\u00fcller, J. & Skakkebaeck, N. E. Proliferation of Sertoli cells during development of the human testis assessed by stereological methods. Int. J. Androl. 10, 589\u2013596 (1987).","journal-title":"Int. J. Androl."},{"key":"BFnrendo2011164_CR104","doi-asserted-by":"publisher","first-page":"2110","DOI":"10.1093\/humrep\/deg413","volume":"18","author":"RM Sharpe","year":"2003","unstructured":"Sharpe, R. M.  et al. Role of the neonatal period of pituitary-testicular activity in germ cell proliferation and differentiation in the primate testis. Hum. Reprod. 18, 2110\u20132117 (2003).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2011164_CR105","doi-asserted-by":"publisher","first-page":"5113","DOI":"10.1210\/jc.2002-020032","volume":"87","author":"EB Berensztein","year":"2002","unstructured":"Berensztein, E. B., Sciara, M. I., Rivarola, M. A. & Belgorosky, A. Apoptosis and proliferation of human testicular somatic and germ cells during prepuberty: high rate of testicular growth in newborns mediated by decreased apoptosis. J. Clin. Endocrinol. Metab. 87, 5113\u20135118 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR106","doi-asserted-by":"publisher","first-page":"787","DOI":"10.1002\/jemt.20754","volume":"72","author":"RA Rey","year":"2009","unstructured":"Rey, R. A., Musse, M., Venara, M. & Chemes, H. E. Ontogeny of the androgen receptor expression in the fetal and postnatal testis: its relevance on Sertoli cell maturation and the onset of adult spermatogenesis. Microsc. Res. Tech. 72, 787\u2013795 (2009).","journal-title":"Microsc. Res. Tech."},{"key":"BFnrendo2011164_CR107","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1111\/j.1651-2227.1982.tb09552.x","volume":"71","author":"D Evain-Brion","year":"1982","unstructured":"Evain-Brion, D., Gendrel, D., Bozzola, M., Chaussain, J. L. & Job, J. C. Diagnosis of Kallmann's syndrome in early infancy. Acta Paediatr. Scand. 71, 937\u2013940 (1982).","journal-title":"Acta Paediatr. Scand."},{"key":"BFnrendo2011164_CR108","doi-asserted-by":"publisher","first-page":"2796","DOI":"10.1002\/ajmg.a.33442","volume":"152A","author":"JD Kaplan","year":"2010","unstructured":"Kaplan, J. D., Bernstein, J. A., Kwan, A. & Hudgins, L. Clues to an early diagnosis of Kallmann syndrome. Am. J. Med. Genet. A 152A, 2796\u20132801 (2010).","journal-title":"Am. J. Med. Genet. A"},{"key":"BFnrendo2011164_CR109","doi-asserted-by":"publisher","first-page":"4128","DOI":"10.1210\/jc.2002-020518","volume":"87","author":"N Pitteloud","year":"2002","unstructured":"Pitteloud, N.  et al. Predictors of outcome of long-term GnRH therapy in men with idiopathic hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 87, 4128\u20134136 (2002).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR110","doi-asserted-by":"publisher","first-page":"5225","DOI":"10.1210\/jc.2010-1535","volume":"95","author":"R Coutant","year":"2010","unstructured":"Coutant, R.  et al. Baseline inhibin B and anti-Mullerian hormone measurements for diagnosis of hypogonadotropic hypogonadism (HH) in boys with delayed puberty. J. Clin. Endocrinol. Metab. 95, 5225\u20135232 (2010).","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"Suppl. 3","key":"BFnrendo2011164_CR111","doi-asserted-by":"publisher","first-page":"U89","DOI":"10.1530\/eje.0.151u089","volume":"151","author":"HA Delemarre-van de Waal","year":"2004","unstructured":"Delemarre-van de Waal, H. A. Application of gonadotropin releasing hormone in hypogonadotropic hypogonadism-diagnostic and therapeutic aspects. Eur. J. Endocrinol. 151 (Suppl. 3), U89\u2013U94 (2004).","journal-title":"Eur. J. Endocrinol."},{"issue":"Suppl. 1","key":"BFnrendo2011164_CR112","doi-asserted-by":"publisher","first-page":"S9","DOI":"10.1530\/EJE-08-0314","volume":"159","author":"EM Delemarre","year":"2008","unstructured":"Delemarre, E. M., Felius, B. & Delemarre-van de Waal, H. A. Inducing puberty. Eur. J. Endocrinol. 159 (Suppl. 1), S9\u2013S15 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR113","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/ncpendmet0450","volume":"3","author":"EJ Richmond","year":"2007","unstructured":"Richmond, E. J. & Rogol, A. D. Male pubertal development and the role of androgen therapy. Nat. Clin. Pract. Endocrinol. Metab. 3, 338\u2013344 (2007).","journal-title":"Nat. Clin. Pract. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR114","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1016\/j.fertnstert.2011.03.091","volume":"95","author":"S Trabado","year":"2011","unstructured":"Trabado, S.  et al. Estradiol levels in men with congenital hypogonadotropic hypogonadism and the effects of different modalities of hormonal treatment. Fertil. Steril. 95, 2324\u20132329.e1\u2013e3 (2011).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR115","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1210\/jc.2010-0266","volume":"96","author":"GR Cunningham","year":"2011","unstructured":"Cunningham, G. R. & Toma, S. M. Clinical review: Why is androgen replacement in males controversial? J. Clin. Endocrinol. Metab. 96, 38\u201352 (2011).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR116","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/S0022-3476(99)70244-1","volume":"134","author":"B Bin-Abbas","year":"1999","unstructured":"Bin-Abbas, B., Conte, F. A., Grumbach, M. M. & Kaplan, S. L. Congenital hypogonadotropic hypogonadism and micropenis: effect of testosterone treatment on adult penile size why sex reversal is not indicated. J. Pediatr. 134, 579\u2013583 (1999).","journal-title":"J. Pediatr."},{"key":"BFnrendo2011164_CR117","doi-asserted-by":"publisher","first-page":"3310","DOI":"10.1210\/jc.2006-0218","volume":"91","author":"C Bouvattier","year":"2006","unstructured":"Bouvattier, C., Mignot, B., Lef\u00e8vre, H., Morel, Y. & Bougn\u00e8res, P. Impaired sexual activity in male adults with partial androgen insensitivity. J. Clin. Endocrinol. Metab. 91, 3310\u20133315 (2006).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR118","first-page":"1545","volume":"77","author":"G Schaison","year":"1993","unstructured":"Schaison, G., Young, J., Pholsena, M., Nahoul, K. & Couzinet, B. Failure of combined follicle-stimulating hormone-testosterone administration to initiate and\/or maintain spermatogenesis in men with hypogonadotropic hypogonadism. J. Clin. Endocrinol. Metab. 77, 1545\u20131549 (1993).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR119","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1007\/BF03346659","volume":"33","author":"AA Sinisi","year":"2010","unstructured":"Sinisi, A. A.  et al. Efficacy of recombinant human follicle stimulating hormone at low doses in inducing spermatogenesis and fertility in hypogonadotropic hypogonadism. J. Endocrinol. Invest. 33, 618\u2013623 (2010).","journal-title":"J. Endocrinol. Invest."},{"key":"BFnrendo2011164_CR120","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0889-8529(18)30072-0","volume":"23","author":"AM Matsumoto","year":"1994","unstructured":"Matsumoto, A. M. Hormonal therapy of male hypogonadism. Endocrinol. Metab. Clin. North Am. 23, 857\u2013875 (1994).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFnrendo2011164_CR121","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1056\/NEJM198509123131102","volume":"313","author":"DM Finkel","year":"1985","unstructured":"Finkel, D. M., Phillips, J. L. & Snyder, P. J. Stimulation of spermatogenesis by gonadotropins in men with hypogonadotropic hypogonadism. N. Eng. J. Med. 313, 651\u2013655 (1985).","journal-title":"N. Eng. J. Med."},{"key":"BFnrendo2011164_CR122","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1093\/humrep\/12.5.980","volume":"12","author":"S Burqu\u00e9s","year":"1997","unstructured":"Burqu\u00e9s, S. & Calder\u00f2n, M. D. Subcutaneous self-administration of highly purified follicle stimulating hormone and human chorionic gonadotrophin for the treatment of male hypogonadotrophic hypogonadism. Spanish Collaborative Group on Male Hypogonadotropic Hypogonadism. Hum. Reprod. 12, 980\u2013986 (1997).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2011164_CR123","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/S0015-0282(16)60084-5","volume":"50","author":"AS Burris","year":"1988","unstructured":"Burris, A. S., Clark, R. V., Vantman, D. J. & Sherins, R. J. A low sperm concentration does not preclude fertility in men with isolated hypogonadotropic hypogonadism after gonadotropin therapy. Fertil. Steril. 50, 343\u2013347 (1988).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR124","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1530\/eje.0.1390298","volume":"139","author":"D B\u00fcchter","year":"1998","unstructured":"B\u00fcchter, D., Behre, H. M., Kliesch, S. & Nieschlag, E. Pulsatile GnRH or human chorionic gonadotropin\/human menopausal gonadotropin as effective treatment for men with hypogonadotropic hypogonadism: a review of 42 cases. Eur. J. Endocrinol. 139, 298\u2013303 (1998).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR125","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1016\/S0015-0282(16)54493-8","volume":"56","author":"W Saal","year":"1991","unstructured":"Saal, W., Happ, J., Cordes, U., Baum, R. P. & Schmidt, M. Subcutaneous gonadotropin therapy in male patients with hypogonadotropic hypogonadism. Fertil. Steril. 56, 319\u2013324 (1991).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR126","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1365-2605.1994.tb01249.x","volume":"17","author":"AW Kung","year":"1994","unstructured":"Kung, A. W., Zhong, Y. Y., Lam, K. S. & Wang, C. Induction of spermatogenesis with gonadotrophins in Chinese men with hypogonadotrophic hypogonadism. Int. J. Androl 17, 241\u2013247 (1994).","journal-title":"Int. J. Androl"},{"key":"BFnrendo2011164_CR127","doi-asserted-by":"publisher","first-page":"1540","DOI":"10.1093\/humrep\/14.6.1540","volume":"14","author":"PY Liu","year":"1999","unstructured":"Liu, P. Y.  et al. Efficacy and safety of recombinant human follicle stimulating hormone (Gonal-F) with urinary human chorionic gonadotrophin for induction of spermatogenesis and fertility in gonadotrophin-deficient men. Hum. Reprod. 14, 1540\u20131545 (1999).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2011164_CR128","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1093\/humrep\/17.3.625","volume":"17","author":"PY Liu","year":"2002","unstructured":"Liu, P. Y.  et al. Predicting pregnancy and spermatogenesis by survival analysis during gonadotrophin treatment of gonadotrophin-deficient infertile men. Hum. Reprod. 17, 625\u2013633 (2002).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2011164_CR129","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1111\/j.1749-6632.1984.tb38305.x","volume":"438","author":"HG Burger","year":"1984","unstructured":"Burger, H. G. & Baker, H. W. Therapeutic considerations and results of gonadotropin treatment in male hypogonadotropic hypogonadism. Ann. NY Acad. Sci. 438, 447\u2013453 (1984).","journal-title":"Ann. NY Acad. Sci."},{"key":"BFnrendo2011164_CR130","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/S0889-8529(05)70039-6","volume":"27","author":"FJ Hayes","year":"1998","unstructured":"Hayes, F. J., Seminara, S. B. & Crowley, W. F. Jr. Hypogonadotropic hypogonadism. Endocrinol. Metab. Clin. North Am. 27, 739\u2013763 (1998).","journal-title":"Endocrinol. Metab. Clin. North Am."},{"key":"BFnrendo2011164_CR131","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/j.1365-2605.1992.tb01131.x","volume":"15","author":"E Vicari","year":"1992","unstructured":"Vicari, E.  et al. Therapy with human chorionic gonadotropin alone induces spermatogenesis in men with isolated hypogonadotrophic hypogonadism-long-term follow-up. Int. J. Androl. 15, 320\u2013329 (1992).","journal-title":"Int. J. Androl."},{"key":"BFnrendo2011164_CR132","doi-asserted-by":"publisher","first-page":"1184","DOI":"10.1210\/jcem-62-6-1184","volume":"62","author":"AM Matsumoto","year":"1986","unstructured":"Matsumoto, A. M., Karpas, A. E. & Bremner, W. J. Chronic human chorionic gonadotropin administration in normal men: evidence that follicle-stimulating hormone is necessary for the maintenance of quantitatively normal spermatogenesis in man. J. Clin. Endocrinol. Metab. 62, 1184\u20131192 (1986).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR133","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1159\/000180284","volume":"23","author":"A Okuyama","year":"1986","unstructured":"Okuyama, A.  et al. Testicular responsiveness to long-term administration of hCG and hMG in patients with hypogonadotropic hypogonadism. Horm. Res. 23, 21\u201330 (1986).","journal-title":"Horm. Res."},{"key":"BFnrendo2011164_CR134","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1111\/j.1365-2265.1994.tb03785.x","volume":"41","author":"JM Kirk","year":"1994","unstructured":"Kirk, J. M., Savage, M. O., Grant, D. B., Bouloux, P. M. & Besser, G. M. Gonadal function and response to human chorionic and menopausal gonadotrophic therapy in male patients with idiopathic hypogonadotrophic hypogonadism. Clin. Endocrinol. (Oxf.) 41, 57\u201363 (1994).","journal-title":"Clin. Endocrinol. (Oxf.)"},{"key":"BFnrendo2011164_CR135","doi-asserted-by":"crossref","unstructured":"[No authors listed] Efficacy and safety of highly purified urinary follicle-stimulating hormone with human chorionic gonadotropin for treating men with isolated hypogonadotropic hypogonadism. European Metrodin HP Study Group. Fertil. Steril. 70, 256\u2013262 (1998).","DOI":"10.1016\/S0015-0282(98)00156-3"},{"key":"BFnrendo2011164_CR136","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1016\/S0015-0282(16)54730-X","volume":"56","author":"J Schopohl","year":"1991","unstructured":"Schopohl, J., Mehltretter, G., von Zumbusch, R., Eversmann, T. & von Werder, K. Comparison of gonadotropin-releasing hormone and gonadotropin therapy in male patients with idiopathic hypothalamic hypogonadism. Fertil. Steril. 56, 1143\u20131150 (1991).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR137","doi-asserted-by":"publisher","first-page":"1326","DOI":"10.1016\/S0015-0282(16)57619-5","volume":"63","author":"S Kliesch","year":"1995","unstructured":"Kliesch, S., Behre, H. M. & Nieschlag, E. Recombinant human follicle-stimulating hormone and human chorionic gonadotropin for induction of spermatogenesis in a hypogonadotropic male. Fertil. Steril. 63, 1326\u20131328 (1995).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR138","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/S0015-0282(01)02973-9","volume":"77","author":"P Bouloux","year":"2002","unstructured":"Bouloux, P., Warne, D. W. & Loumaye, E. Efficacy and safety of recombinant human follicle-stimulating hormone in men with isolated hypogonadotropic hypogonadism. Fertil. Steril. 77, 270\u2013273 (2002).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR139","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1002\/j.1939-4640.2003.tb02712.x","volume":"24","author":"PM Bouloux","year":"2003","unstructured":"Bouloux, P. M.  et al. Induction of spermatogenesis by recombinant follicle-stimulating hormone (puregon) in hypogonadotropic azoospermic men who failed to respond to human chorionic gonadotropin alone. J. Androl. 24, 604\u2013611 (2003).","journal-title":"J. Androl."},{"key":"BFnrendo2011164_CR140","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1016\/j.fertnstert.2008.07.1720","volume":"2","author":"DW Warne","year":"2009","unstructured":"Warne, D. W.  et al. A combined analysis of data to identify predictive factors for spermatogenesis in men with hypogonadotropic hypogonadism treated with recombinant human follicle-stimulating hormone and human chorionic gonadotropin. Fertil. Steril. 2, 594\u2013604 (2009).","journal-title":"Fertil. Steril."},{"key":"BFnrendo2011164_CR141","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1210\/jc.2008-1648","volume":"94","author":"PY Liu","year":"2009","unstructured":"Liu, P. Y.  et al. Induction of spermatogenesis and fertility during gonadotropin treatment of gonadotropin-deficient infertile men: predictors of fertility outcome. J. Clin. Endocrinol. Metab. 94, 801\u2013808 (2009).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR142","doi-asserted-by":"publisher","first-page":"83","DOI":"10.3109\/14647271003639723","volume":"13","author":"NB Oldereid","year":"2010","unstructured":"Oldereid, N. B., Abyholm, T. & Tanbo, T. G. Spermatogenesis and fertility outcome in male hypogonadotrophic hypogonadism. Hum. Fertil. (Camb.) 13, 83\u201389 (2010).","journal-title":"Hum. Fertil. (Camb.)"},{"key":"BFnrendo2011164_CR143","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/S0090-4295(96)00359-7","volume":"49","author":"I Nane","year":"1997","unstructured":"Nane, I.  et al. Primary gonadotropin releasing hormone and adjunctive human chorionic gonadotropin treatment in cryptorchidism: a clinical trial. Urology 49, 108\u2013111 (1997).","journal-title":"Urology"},{"issue":"Suppl. 1","key":"BFnrendo2011164_CR144","doi-asserted-by":"publisher","first-page":"S87","DOI":"10.1530\/EJE-08-0181","volume":"159","author":"EM Ritz\u00e9n","year":"2008","unstructured":"Ritz\u00e9n, E. M. Undescended testes: a consensus on management. Eur. J. Endocrinol. 159 (Suppl. 1), S87\u2013S90 (2008).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR145","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1093\/humupd\/dmi039","volume":"12","author":"L Aksglaede","year":"2006","unstructured":"Aksglaede, L.  et al. Natural history of seminiferous tubule degeneration in Klinefelter syndrome. Hum. Reprod. Update. 12, 39\u201348 (2006).","journal-title":"Hum. Reprod. Update."},{"key":"BFnrendo2011164_CR146","doi-asserted-by":"publisher","first-page":"204","DOI":"10.3109\/14647270903331139","volume":"12","author":"B Resorlu","year":"2009","unstructured":"Resorlu, B., Abdulmajed, M. I., Kara, C., Unsal, A. & Aydos, K. Is intracytoplasmic sperm injection essential for the treatment of hypogonadotrophic hypogonadism? A comparison between idiopathic and secondary hypogonadotrophic hypogonadism. Hum. Fertil. (Camb.) 12, 204\u2013208 (2009).","journal-title":"Hum. Fertil. (Camb.)"},{"key":"BFnrendo2011164_CR147","doi-asserted-by":"publisher","first-page":"724","DOI":"10.1093\/humrep\/deq372","volume":"26","author":"C Frapsauce","year":"2011","unstructured":"Frapsauce, C.  et al. Birth after TESE-ICSI in a man with hypogonadotropic hypogonadism and congenital adrenal hypoplasia linked to a DAX-1 (NR0B1) mutation. Hum. Reprod. 26, 724\u2013728 (2011).","journal-title":"Hum. Reprod."},{"key":"BFnrendo2011164_CR148","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(05)62227-1","volume":"350","author":"T Raivio","year":"1997","unstructured":"Raivio, T., Toppari, J., Perheentupa, A., McNeilly, A. S. & Dunkel, L. Treatment of prepubertal gonadotrophin-deficient boys with recombinant human follicle-stimulating hormone. Lancet 350, 263\u2013264 (1997).","journal-title":"Lancet"},{"key":"BFnrendo2011164_CR149","first-page":"339","volume":"12","author":"C Bouvattier","year":"1999","unstructured":"Bouvattier, C., Tauber, M., Jouret, B., Chaussain, J. L. & Rochiccioli, P. Gonadotropin treatment of hypogonadotropic hypogonadal adolescents. J. Pediatr. Endocrinol. Metab. 12, 339\u2013344 (1999).","journal-title":"J. Pediatr. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR150","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1530\/eje.1.02315","volume":"156","author":"T Raivio","year":"2007","unstructured":"Raivio, T. Wikstr\u00f6m, A. M. & Dunkel, L. Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome. Eur. J. Endocrinol. 156, 105\u2013111 (2007).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR151","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1530\/eje.0.1460075","volume":"146","author":"KM Main","year":"2002","unstructured":"Main, K. M., Schmidt, I. M., Toppari, J. & Skakkebaek, N. E. Early postnatal treatment of hypogonadotropic hypogonadism with recombinant human FSH and LH. Eur. J. Endocrinol. 146, 75\u201379 (2002).","journal-title":"Eur. J. Endocrinol."},{"key":"BFnrendo2011164_CR152","doi-asserted-by":"publisher","first-page":"4905","DOI":"10.1210\/jcem.85.12.7058","volume":"85","author":"KM Main","year":"2000","unstructured":"Main, K. M., Schmidt, I. M. & Skakkebaek, N. E. A possible role for reproductive hormones in newborn boys: progressive hypogonadism without the postnatal testosterone peak. J. Clin. Endocrinol. Metab. 85, 4905\u20134907 (2000).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR153","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1210\/jc.2008-0121","volume":"93","author":"P Bougn\u00e8res","year":"2008","unstructured":"Bougn\u00e8res, P.  et al. Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone. J. Clin. Endocrinol. Metab. 93, 2202\u20132205 (2008).","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"BFnrendo2011164_CR154","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1159\/000181058","volume":"30","author":"P Christiansen","year":"1988","unstructured":"Christiansen, P.  et al. Treatment of cryptorchidism with human chorionic gonadotropin or gonadotropin releasing hormone. A double-blind controlled study of 243 boys. Horm. Res. 30, 187\u2013192 (1988).","journal-title":"Horm. Res."},{"key":"BFnrendo2011164_CR155","doi-asserted-by":"publisher","first-page":"2341","DOI":"10.1172\/JCI119773","volume":"100","author":"L Dunkel","year":"1997","unstructured":"Dunkel, L., Taskinen, S., Hovatta, O., Tilly, J. L. & Wikstr\u00f6m, S. Germ cell apoptosis after treatment of cryptorchidism with human chorionic gonadotropin is associated with impaired reproductive function in the adult. J. Clin. Invest. 100, 2341\u20132346 (1997).","journal-title":"J. Clin. Invest."},{"key":"BFnrendo2011164_CR156","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1007\/s00441-005-1143-3","volume":"322","author":"M Kaleva","year":"2005","unstructured":"Kaleva, M. & Toppari, J. Cryptorchidism: an indicator of testicular dysgenesis? Cell Tissue Res. 322, 167\u2013172 (2005).","journal-title":"Cell Tissue Res."},{"key":"BFnrendo2011164_CR157","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1095\/biolreprod63.1.82","volume":"63","author":"S Ramaswamy","year":"2000","unstructured":"Ramaswamy, S., Plant, T. M. & Marshall, G. R. Pulsatile stimulation with recombinant single chain human luteinizing hormone elicits precocious sertoli cell proliferation in the juvenile male rhesus monkey (Macaca mulatta). Biol. Reprod. 63, 82\u201388 (2000).","journal-title":"Biol. Reprod."}],"container-title":["Nature Reviews Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2011.164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2011.164","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/nrendo.2011.164.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:36:51Z","timestamp":1684467411000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/nrendo.2011.164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,10,18]]},"references-count":157,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2012,3]]}},"alternative-id":["BFnrendo2011164"],"URL":"https:\/\/doi.org\/10.1038\/nrendo.2011.164","relation":{},"ISSN":["1759-5029","1759-5037"],"issn-type":[{"value":"1759-5029","type":"print"},{"value":"1759-5037","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,10,18]]}}}